Abstract-Hypertensive heart disease is characterized by early development of hypertrophy and fibrosis that leads to heart failure (HF). HF develops in spontaneously hypertensive rats (SHR) after 18 months; however, it is not clear whether hypertrophy leads to altered cardiac performance at an earlier age in these rats. We studied cardiac performance in 10-to 11-month-old SHR and age-matched Wistar-Kyoto rats (WKY), using presssure-volume (PV) conductance catheter system to evaluate systolic and diastolic function in vivo at different preloads, including preload recruitable stroke work (PRSW), ϩdP/dt, and its relation to end-diastolic volume (ϩdP/dt-EDV) and preload-adjusted maximal power (PWR max -EDV 2 ) as well as the time constant of left ventricular pressure decay, tau (), as an index of relaxation. The slope of the end-diastolic pressure-volume relation (EDPVR) and the ex vivo PV relation, both indexes of stiffness, were also calculated for each heart, and the Doppler E/A ratio was determined. In addition, plasma samples were obtained to assess B-type natriuretic peptide levels (BNP). We found that PRSW was higher in SHR than in WKY (174.5Ϯ15.6 versus 92.6Ϯ18.9 mm Hg; PϽ0.01). ϩdP/dt and ϩdP/dt-EDV were also enhanced in SHR versus WKY (9125Ϯ662 versus 6633Ϯ392 mm Hg/sec, PϽ0.01, and 28.14Ϯ4.35 versus 12.7Ϯ2.8 mm Hg/s per L, PϽ0.02). In addition, PWR-EDV 2 was elevated in SHR (7.3Ϯ1.5 versus 3.1Ϯ0.6 mW/L 2 ). was prolonged in SHR (14.5Ϯ1 ms versus 10.8Ϯ0.8 for WKY, PϽ0.02) and EDPVR was significantly greater in SHR than in WKY (0.01Ϯ0.005 versus 0.004Ϯ0.001, PϽ0.05). The ex vivo pressure-volume relation was also steeper for SHR and the E/A ratio was 2.53Ϯ0.15 for SHR versus 1.67Ϯ0.08 for WKY (PϽ0.02). BNP was 45Ϯ2.5 pg/mL for SHR and 33.3Ϯ1.8 pg/mL for WKY (PϽ0.02). Taken together, these data suggest that at 10 to 11 months of age, before HF develops, SHR have increased systolic performance accompanied by delayed relaxation and increased diastolic stiffness. 
T he heart is one of the main target organs in hypertension. Changes in myocyte expression of both contractile and noncontractile proteins and increased interstitial fibrosis are typically found during the natural course of hypertensive heart disease and result in progressive pathological hypertrophy, which may lead to heart failure (HF). [1] [2] [3] [4] However, it is not clear how hypertrophy affects cardiac performance before the development of HF. Several studies involving different experimental models of pressure-induced hypertrophy have demonstrated that systolic performance is either normal, increased, or decreased before the development of HF. These discrepancies may be due to the different models studied, when the experiments were performed in relation to the development of hypertrophy and how cardiac function was evaluated. [5] [6] [7] [8] The spontaneously hypertensive rat (SHR) is a wellestablished model of genetic hypertension, which in certain ways resembles hypertension in humans. 9 Mirsky et al 10 showed that the ejection fraction index-afterload relation was normal in SHR until 18 months, when HF started to develop.
Bing et al 3 also demonstrated that cardiac function was impaired with aging in SHR, highlighting the importance of both myocytes and the interstitium in the transition to HF. Pfeffer et al 11 found cardiac output to be increased in young SHR compared with Wistar-Kyoto rats (WKY), whereas Kobayashi et al 8 found increased contractility in myocytes isolated from older SHR. In contrast, others found no change in contractility in these animals, again raising questions about this issue. 12 More recently, investigators have focused on diastolic dysfunction as an early marker of target organ damage in hypertension. 8, 13, 14 Diastolic dysfunction can be due to alterations in relaxation and/or myocardial stiffness. [15] [16] [17] [18] It is well known from clinical data, as well as from some animal models, that alterations in diastole precede the development of HF in hypertensive heart disease. However, in many of these studies systolic and diastolic function were evaluated using different methods, some of which were compromised by loading dependency. 3, 19 We studied systolic and diastolic function in adult 10-to 11-month-old SHR and WKY using a micromanometer-conductance catheter system at different preloads to incorporate volume measurement in the assessment of cardiac performance and thereby eliminate load dependency. We wanted to test the hypothesis that in these adult hypertensive rats, enhanced cardiac mass leads to increased systolic performance in the presence of diastolic dysfunction. We also wanted to determine whether diastolic dysfunction is due to alterations in relaxation, stiffness, or both. To this end, we calculated preload-recruitable stroke work (PRSW), maximum dP/dt-end-diastolic volume relation (ϩdP/dt-EDV), and preload adjusted maximal power (PWR max /EDV 2 ) to assess systolic performance and the time constant of left ventricular (LV) pressure decay, tau () as a parameter of relaxation. 20 The slope of the end-diastolic pressure-volume relation (EDPVR), an indicator of end-diastolic stiffness and Doppler early to late transmitral peak flow velocity ratio (E/A) were determined at the same time to evaluate diastolic function. We also obtained ex vivo pressure-volume (PV) curves after arresting the heart with KCl.
Methods

Animals and Procedures
Nine-to ten-month-old SHR and WKY from Taconic Farms were housed and maintained at a constant room temperature (22°Celsius) and 12-hour light/dark cycle. They were fed standard rat chow and given water ad libitum. After remaining in the animal facility for 1 week, blood pressure was measured once a week for 3 weeks by the tail-cuff method. By the fourth week, when they were 10 to 11 months old, rats were anesthetized with the long-lasting agent thiobutabarbital (Inactin, 100 mg/kg IP). Additional boluses of 10 mg/kg were given if necessary to stabilize anesthesia. The abdomen, chest, and neck were shaved, and the following procedures were performed: (1) echocardiography and Doppler; (2) in vivo cardiac PV loops; (3) ex vivo PV relationships.
Blood samples were obtained from the inferior vena cava for BNP determination at the end of the in vivo experiments, and the animals were euthanized.
Echocardiography and Doppler
Echocardiography and Doppler (Acuson, Sequoia C 256 with 15-MHz transducer) were performed while simultaneously recording ECG.
M-mode echocardiography was performed in the anterior shortaxis view. LV posterior wall thickness was determined at the end of both diastole and systole. Pulsed-wave Doppler early to late transmitral peak diastolic flow velocity ratio (E/A) was measured to assess diastolic function as described previously. 14, 21 Aortic systolic velocity-time integral (VTI) and aortic root diameter were determined and stroke volume calculated according to this formula:
Stroke volumeϭ(VTI)( r 2 ), where rϭaortic diameter/2. All Doppler spectra were recorded for 5 to 7 cardiac cycles at a sweep speed of 200 mm/s.
In Vivo PV Loops
Once the echocardiographic measurements were obtained, animals were placed on a warm pad (37°C). The right jugular vein was cannulated for fluid administration, and a 14-gauge catheter was placed in the trachea. They were ventilated with a positive-pressure ventilator (Harvard, model 680) with an FiO 2 of 0.21. Hetastarch (6%) in 0.9% NaCl was infused intravenously during the procedure (200 L/kg per minute for 10 minutes; then 20 L/kg per minute throughout the experiment). The abdomen was opened and the diaphragm incised to reach the heart. A small stab was made with a 26-gauge needle at the LV apex, and a 2F miniaturized combined conductance catheter-micromanometer (model SPR-819, Millar Instruments) connected to a pressure-conductance unit (MPCU-200, Millar) was advanced retrograde into the LV along the cardiac longitudinal axis as described previously in mice by Georgakopoulos and Kass. 22 This catheter has a micromanometer surrounded by 4 platinum electrodes; the two outermost electrodes generate a current of 0.1 mA at a frequency of 20 kHz, which is sensed by the two innermost electrodes. Catheter position was confirmed by echocardiography. Pressure was calibrated against a mercury column after placing the catheter in warm 0.9% NaCl solution for 30 minutes. PV loops were recorded at baseline and during unloading by gently occluding the inferior vena cava with a cotton swab. Time-varying volume was obtained as described elsewhere, [22] [23] [24] according to this formula:
, where Vϭvolume, Gtotϭtotal conductance, Gpϭparallel conductance of surrounding structures, Lϭdistance between catheter electrodes (9 mm), and ϭconductiv-ity of blood.
Doppler was performed simultaneously for stroke volume determination and calculation of the constant ␣ (␣ϭSVccs/SVecho), where SVccsϭstroke volume measured by the conductance catheter and SVechoϭstroke volume measured by Doppler echocardiography. ␣ varied in our experiments from 0.8 to 1.1.
Parallel conductance from surrounding structures was calculated by injecting a small bolus of 30% NaCl through the jugular vein. 25 Data were stored and analyzed by using Millar conductance data acquisition and analysis software. The following parameters were calculated: end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), ejection fraction (EF), end-systolic PV relation (ESPVR), end-diastolic PV relation (EDPVR), maximum dP/dt (ϩdP/dt), minimum dP/dt (ϪdP/dt), tau (), maximum dP/dt-enddiastolic volume (ϩdP/dt-EDV), preload recruitable stroke work (PRSW), and preload-adjusted maximal power (PWR max -EDV 2 ).
Ex Vivo PV Relation
Immediately after terminating each in vivo experiment, hearts were stopped with 15% KCl and removed. A PE-50 tube connected to a pressure transducer (Gould Instruments) was passed into the LV through the aorta. The atrioventricular groove was sealed with 4 -0 silk. Saline solution (0.9% NaCl) was infused through the apex at a constant rate (675 L/min) after aspirating the LV to generate a negative pressure of Ϫ5 mm Hg, as described by Raya et al. 26 The right ventricle was incised to avoid fluid accumulation. At least 2 PV curves (from Ϫ5 to 30 mm Hg) were obtained in each heart within 10 minutes after arrest. Volumes were corrected by the chamber volume at 0 mm Hg pressure.
End-Systolic Stress and Mean Velocity of Circumferential Fiber Shortening Calculations
The LV end-systolic and end-diastolic radii were calculated from the respective volumes, assuming that the heart has a spherical shape with radius R. Midwall circumferential end-systolic stress () was calculated according to the formula ϭ(PR 2 /h)/(2Rϩh) 3 , where P is end-systolic pressure, R is chamber radius (both calculated from the conductance catheter), and h is wall thickness, determined by echocardiography.
The ejection time of each heart was calculated from the duration of the VTI and corrected for HR. The mean velocity of circumferential fiber shortening (Vcf) was determined by dividing the shortening fraction by the rate-corrected ejection time according to the formula Vcfϭ(EDDϪESD)/EDD · ET 27 , where EDDϭend-diastolic dimension, ESDϭend-systolic dimension, and ETϭrate-corrected ejection time.
Statistical Analysis
Results were expressed as meanϮSEM. Differences between groups were compared by Student t test. A value of PϽ0.05 was used as a criterion for statistical significance.
Results
Systolic blood pressure, heart rate, body weight, and LV weight are shown in the Table. SHR were smaller and had a faster heart rate than WKY. LVW/BW was significantly higher in SHR. Also, the ratio of LV radius to posterior wall thickness (R/H) was reduced by 37% in SHR (1.68Ϯ0.01 versus 2.31Ϯ0.07 in WKY), indicating increased concentricity in the hypertensive animals. Figure 1 shows that EDV and SV were slightly higher in WKY, although the difference was not significant. EF was normal and similar in both strains, whereas EDP tended to be higher in the hypertensive rats (9.6Ϯ1.6 mm Hg versus 5.9Ϯ0.7 for WKY; Pϭ0.08).
Plasma BNP, a marker of pressure-overloaded, was significantly increased in SHR (45Ϯ2.5 pg/mL versus 33.3Ϯ1.8 for WKY; PϽ0.05). Figure 2 shows typical PV loops obtained after inferior vena cava occlusion in both strains, and overall results of EDPVR and ESPVR are shown in Figure 3 . EDPVR differed between strains (0.01Ϯ0.005 versus 0.004Ϯ0.001 mm Hg/ L for SHR and WKY, respectively; PϽ0.02), suggesting that end-diastolic stiffness is increased in SHR. ESPVR was 1.14Ϯ0.24 mm Hg/L for SHR versus 0.36Ϯ0.11 for WKY (PϽ0.02), suggesting increased systolic performance in the hypertensive rats.
In addition to the above parameters, PV loops recorded at different preloads can be used to derive other useful systolic function indexes that may be influenced less by loading conditions and cardiac mass. One of them is PRSW. This index is a modification of Sarnoff's curve and represents the slope of the relation between stroke work and EDV. It has been described as independent of chamber size and mass and is sensitive to changes in contractile function. 28 Figure 4A shows PRSW for one SHR and its normotensive control. The slope is steeper in SHR than in WKY, indicating increased systolic performance. The figure also shows that overall PRSW was 174.5Ϯ15.6 mm Hg for SHR versus 92.6Ϯ18.9 for WKY (PϽ0.01). We also determined the relation between ϩdP/dt and EDV. ϩdP/dt is a classic parameter that is quite sensitive to changes in contractility but dependent on changes in preload. Analysis of the ϩdP/dt end-diastolic volume relation allowed us to compare ϩdP/dt of SHR and WKY at a given end-diastolic volume. Figure 4B shows that the slope of this relation was steeper in SHR (28.4Ϯ4.35 versus 12.7Ϯ2.8 mm Hg/s per L for WKY; PϽ0.02), again indicating enhanced contractility.
Another parameter that may be useful for assessing changes in systolic performance is preload-adjusted maximal ventricular power (PWR max /EDV 2 ). 28 Maximal power is the instantaneous peak product of pressure and flow and is highly dependent on preload. Dividing maximal power by the square of the end-diastolic volume (PWR max /EDV 2 ) yields an index that is minimally influenced by vascular loading. Changes in this parameter between SHR and WKY (7.3Ϯ1.5 versus 3.1Ϯ0.6 W/L 2 , respectively; PϽ0.05) also suggest increased systolic performance in these hypertensive animals. Figure 5 shows that although ϩdP/dt was augmented in SHR (9125Ϯ662 versus 6633Ϯ392 mm Hg/s for WKY; PϽ0.01), 
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ϪdP/dt (the maximal velocity of the drop in pressure) was not significantly different. According to this, the ratio between both maximal velocities increased, suggesting a negative lusitropic pattern in the hypertrophic heart of SHR. The time constant of isovolumic pressure decay increased by Ϸ40% in these animals (14.5Ϯ1 versus 10.8Ϯ0.4 ms for SHR and WKY, respectively; PϽ0.05), likewise indicating impaired relaxation; however, the Doppler E/A ratio indicated a predominant "restrictive pattern." The increased EDPVR observed in SHR as well as the increased E/A ratio all suggest that the predominant manifestation of dysfunction is increased end-diastolic stiffness. However, the delayed relaxation assessed by the ratio of ϩdP/dt/ϪdP/dt and the prolonged make it difficult to rule out an incomplete relaxation state that could have influenced EDPVR. Nevertheless, in the ex vivo experiments (Figure 6 ), in which the hearts were quiescent and therefore the delayed relaxation observed in vivo could not account for the shift in the PV relation, the curve was steeper in SHR, confirming the increased stiffness found in the beating heart with the pressure-conductance catheter.
Discussion
To our knowledge, this is the first study comparing the contractile function in SHR with its normotensive control WKY using PV methodology. In addition, we assessed diastolic function in these animals by using this technique and two others. PV analysis is a useful approach for examining the intact chamber function independently of load.
Diastolic dysfunction was expected in the SHR, based on the increased wall thickness and fibrosis and the impaired relaxation and augmented chamber stiffness reported by others using this model. 1, 4, 29 These alterations were detected in vivo in our study, based on the increased EDPVR, the restrictive pattern of the Doppler E/A ratio, and the leftward shift in the PV relation observed in the ex vivo experiments. Impaired relaxation was also detected in our hypertensive animals, as reflected by the prolonged and the fact that for a given maximal velocity of contraction (ϩdP/dt), maximal velocity of relaxation (ϪdP/dt) was decreased. Relaxation, an active process, depends mostly on calcium uptake by the sarcoplasmic reticulum during diastole, and under normal conditions usually takes place during the first third of diastole. End-diastolic stiffness, although it can be influenced by different factors, is affected more by myocardial structural components. We observed both increased stiffness and delayed relaxation in SHR. The fact that chamber compliance was also reduced in these rats in the ex vivo PV experiments suggests the important role played by the passive structural components of the ventricle. The Doppler E/A ratio also supported these findings. Whereas this ratio has been shown in different studies to detect alterations in relaxation early in hypertension ("inverted" E/A ratio), it can also show decreased compliance, usually at a later stage, when the ventricle stiffens. 14, 18 This was the case in our hypertrophic rats, in which according to our findings, stiffness seemed to predominate at this age.
Plasma BNP, a recently accepted indicator of HF, was significantly elevated in the rats with hypertrophy, clearly showing the value of this peptide as an early marker of diastolic dysfunction. Other investigators have observed elevated BNP in patients with isolated diastolic HF. 30 The EF values did not differ between SHR and WKY. EF is known to be influenced by both preload and afterload and therefore cannot reliably be used to assess contractile function in models where both preload and afterload are altered. Instead, all indexes derived from the PV loops showed enhanced contractile pump function in the hypertensive rats. Historically, ESPVR (E es or E max ) was proposed as a fairly load-insensitive index of contractility. ESPVR was increased in SHR; however, as this relation can be altered not only by changes in inotropic state but also by changes in chamber geometry and other diastolic factors, we decided to calculate other parameters as well. 29 PRSW, the linear relation between SW and EDV, may be sensitive to changes in systolic function. It has the advantage of being stable throughout hearts of different sizes; and although it integrates data from the entire cardiac cycle, it is influenced most of all by systole. 31 PRSW was augmented by Ϸ80% in SHR compared with WKY.
ϩdP/dt-EDV, another PV-derived index known to be sensitive to contractile changes and insensitive to preload, also increased by Ϸ100% in SHR. When maximal power normalized for preload (PWR max /EDV 2 ) was determined for both strains, a similar increase was again detected in SHR.
Taking all our data together, we could conclude that the SHR heart has enhanced pump function. According to these results, and considering that most of these adult hypertensive animals that already have diastolic dysfunction will have HF in the next few months, we questioned whether the enhanced contractile function could be the result of an exuberant hypertrophic response leading to an excess of parallel sarcomeres, working each of them with subnormal function. The end-systolic stress-rate corrected mean velocity of circumferential fiber shortening (Vcf) relation, which is known to be independent of heart rate and afterload, can be used to evaluate contractility at the myocardial level (contractile state corrected by chamber radius/wall thickness ratio). 32, 33 By plotting against Vcf, as seen in Figure 7 , we observed that both SHR and WKY showed a similar inverse linear correlation, as described for hearts with similar degrees of inotropism. 33 If sarcomeres were increased in number and inotropism depressed, we would expect to see the same slope for SHR, but with a lower ordinate intercept (ie, lower Vcf for a Relation between ratecorrected mean velocity of circumferential fiber shortening (Vcf) and midwall circumferential end-systolic stress ( es ). An inverse correlation was observed, suggesting similar inotropism for both SHR and WKY once contractile function is corrected for wall stress. ⅷ, SHR; ⅙, WKY.
given level of stress). On the contrary, our findings indicated that although systolic performance of the SHR ventricle is enhanced, this is due to the adequate hypertrophic response observed in this model that compensates for the increased wall stress these myocytes are subject to, which at this point, seems to have preserved inotropism. Increased systolic function with normal inotropic state has been previously described in dogs in a model of short-term hypertrophy. 34 However, we would like to emphasize that the data reported herein cannot necessarily be extrapolated to other models.
In conclusion, compared with WKY, the adult SHR has increased systolic performance with diastolic dysfunction. The supernormal systolic function is due to a compensated hypertrophic response with preserved inotropism. Alterations in both active relaxation and passive compliance characterize the diastolic dysfunction observed in these adult hypertensive animals.
